Compare LKSP & HURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | LKSP | HURA |
|---|---|---|
| Founded | 2024 | 2009 |
| Country | United States | United States |
| Employees | 2 | 22 |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 159.3M | 160.5M |
| IPO Year | N/A | N/A |
| Metric | LKSP | HURA |
|---|---|---|
| Price | $10.16 | $2.39 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.50 |
| AVG Volume (30 Days) | 78.0K | ★ 710.1K |
| Earning Date | 01-01-0001 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $293.18 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.90 | $0.41 |
| 52 Week High | $10.16 | $3.90 |
| Indicator | LKSP | HURA |
|---|---|---|
| Relative Strength Index (RSI) | 65.82 | 52.34 |
| Support Level | $10.09 | $2.09 |
| Resistance Level | N/A | $2.71 |
| Average True Range (ATR) | 0.00 | 0.21 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 100.00 | 43.57 |
Lake Superior Acquisition Corp is a blank check company.
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.